Get the Stockscreener App
47.53
5.80%
2.605
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Conmed Corp stock is traded at $47.53, with a volume of 96,910.
It is up +5.80% in the last 24 hours and up +1.25% over the past month.
Conmed Corp is a medical technology company that provides devices and equipment for surgical procedures. The company's products are used by surgeons and other healthcare professionals across specialties, including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. Geographically, the company operates in the United States, Europe, the Middle East & Africa, Asia Pacific, and the Americas, excluding the United States. The majority of revenue is generated from the United States.
See More
Previous Close:
$44.93
Open:
$45.59
24h Volume:
96,910
Relative Volume:
0.24
Market Cap:
$1.42B
Revenue:
$1.37B
Net Income/Loss:
$54.85M
P/E Ratio:
26.81
EPS:
1.7729
Net Cash Flow:
$123.71M
1W Performance:
+5.38%
1M Performance:
+1.25%
6M Performance:
+20.52%
1Y Performance:
+6.87%
1-Day Range:
$44.89
$47.85
1-Week Range:
$44.09
$46.59
52-Week Range:
$31.44
$53.66
Conmed Corp Stock (CNMD) Company Profile
Name
Conmed Corp
Sector
Industry
Phone
727-214-2974
Address
11311 CONCEPT BOULEVARD, LARGO, NY
Compare CNMD vs ABT, MDT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CNMD
Conmed Corp
|
47.53 | 1.42B | 1.37B | 54.85M | 123.71M | 1.7729 |
ABT
Abbott Laboratories
|
104.47 | 180.77B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
95.28 | 121.88B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
291.70 | 111.89B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
43.77 | 63.43B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.59 | 49.91B | 6.30B | 1.07B | 1.09B | 1.8406 |
Conmed Corp Stock (CNMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-09-26 | Initiated | BMO Capital Markets | Market Perform |
| Jun-29-26 | Downgrade | BofA Securities | Neutral → Underperform |
| Mar-17-26 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jun-12-25 | Downgrade | Needham | Buy → Hold |
| Apr-28-25 | Downgrade | Stifel | Buy → Hold |
| Feb-06-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-01-24 | Reiterated | Needham | Buy |
| May-22-23 | Initiated | CL King | Buy |
| Mar-27-23 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-21-23 | Initiated | Wells Fargo | Equal Weight |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Mar-02-22 | Resumed | BofA Securities | Neutral |
| Oct-06-21 | Upgrade | Needham | Hold → Buy |
| Jul-15-21 | Initiated | UBS | Buy |
| May-25-21 | Initiated | Barclays | Overweight |
| Nov-26-19 | Downgrade | Needham | Buy → Hold |
| Nov-12-19 | Initiated | JP Morgan | Overweight |
| Oct-31-19 | Reiterated | Needham | Buy |
| Oct-04-19 | Reiterated | Needham | Buy |
| Aug-22-19 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Apr-18-19 | Initiated | Stifel | Buy |
| Apr-16-19 | Reiterated | Needham | Buy |
| Jan-23-19 | Reiterated | Needham | Buy |
| Oct-16-18 | Initiated | Barclays | Equal Weight |
| Aug-07-18 | Reiterated | Needham | Buy |
| Aug-02-18 | Reiterated | Needham | Buy |
| Apr-26-18 | Reiterated | Needham | Buy |
| Feb-01-18 | Reiterated | Needham | Buy |
| Jul-27-17 | Reiterated | Needham | Buy |
| Apr-27-17 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Apr-27-17 | Reiterated | Needham | Buy |
| Nov-18-16 | Reiterated | Needham | Buy |
| Jul-28-16 | Downgrade | Leerink Partners | Outperform → Mkt Perform |
| Apr-28-16 | Reiterated | Needham | Buy |
| Oct-22-15 | Reiterated | Northland Capital | Market Perform |
View All
Conmed Corp Stock (CNMD) Latest News
CONMED Corporation (CNMD) Stock forecasts - Yahoo Finance Singapore
CONMED Corporation (NYSE:CNMD) Stock Has Average Price Target of $41.40 - MarketBeat
CONMED Corporation (CNMD) Stock Forecasts - Yahoo! Finance Canada
Conmed Corp (EC8.SG) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
CONMED (NYSE:CNMD) Shares Gap DownHere's Why - MarketBeat
Is Conmed Corp (CNMD) a Bargain After 6.0% Drop? GF Value Says U - GuruFocus
Conmed Corp (EC8.SG) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
CONMED stock gains 2.22 percent ahead of October 28 results - AD HOC NEWS
CONMED stock trades at EUR 41.30 ahead of results - AD HOC NEWS
CONMED stock heads into October 28 results with EPS guidance - AD HOC NEWS
Surgical Equipment & ConsumablesDiversified Stocks Q2 Recap: Benchmarking CONMED (NYSE:CNMD) - Yahoo Finance
CONMED Corporation to Report Third Quarter 2026 Financial Results on October 28, 2026 - Orthopedics This Week
CONMED Corporation to Report Third Quarter 2026 Financial Results on October 28, 2026 - Business Wire
CONMED Corporation to Report Third Quarter 2026 Financial Results on October 28, 2026 - Yahoo Finance
CONMED: Flat Sales, Better Cash, and a More Interesting Story - Orthopedics This Week
CONMED: Flat Sales, Better Cash, and a More Interesting Story - Orthopedics This Week
CONMED Corporation (CNMD) Stock Forecasts - Yahoo Finance
CONMED Corporation (CNMD) Stock forecasts - Yahoo Finance UK
Discipline and Rules-Based Execution in CNMD Response - Stock Traders Daily
CONMED Corporation (CNMD) Stock Forecasts - Yahoo! Finance Canada
Bank of America Corp DE Acquires Shares of 1,341,409 CONMED Corporation $CNMD - MarketBeat
Conmed Corp (EC8.MU) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Conmed Stock Price Forecast. Should You Buy CNMD? - StockInvest.us
Here's Why You Should Retain CONMED Stock in Your Portfolio for Now - finance.yahoo.com
CONMED Director Kim Kelderman Awarded 500 RSUs Under 2025 Long-Term Incentive Plan - Kalkine Media
CONMED (CNMD) director receives 500 shares as stock units vest - Stock Titan
CONMED at Wells Fargo conference: growth story gains momentum By Investing.com - Investing.com India
CONMED at Wells Fargo conference: growth story gains momentum By Investing.com - Investing.com UK
Is Cardinal Health Building a New Tech-Enabled Healthcare Platform? - Zacks Investment Research
Legal & General Group Plc Purchases New Shares in CONMED Corporation $CNMD - MarketBeat
291,203 Shares in CONMED Corporation $CNMD Acquired by Bank of New York Mellon Corp - MarketBeat
CNMD stock slips after Q2 2026 beat as med-tech investors watch guidance - AD HOC NEWS
CONMED Corporation stock gains support from solid earnings and guidance - ad-hoc-news.de
Connor Clark & Lunn Investment Management Ltd. Makes New Investment in CONMED Corporation $CNMD - MarketBeat
Deutsche Bank AG Buys Shares of 32,796 CONMED Corporation $CNMD - MarketBeat
BlackRock Inc. Invests $157.78 Million in CONMED Corporation $CNMD - MarketBeat
Technical Reactions to CNMD Trends in Macro Strategies - Stock Traders Daily
Conmed (CNMD) Up 7.1% Since Last Earnings Report: Can It Continue? - finance.yahoo.com
Algert Global LLC Has $4.30 Million Position in CONMED Corporation $CNMD - MarketBeat
CONMED Corporation to Participate in the Wells Fargo 21st Annual Healthcare Conference - finance.yahoo.com
CONMED Corporation to Participate in the Wells Fargo 21st Annual Healthcare Conference - Business Wire
Paradigm Capital Management Inc. NY Purchases New Position in CONMED Corporation $CNMD - marketbeat.com
3 Reasons to Avoid CNMD and 1 Stock to Buy Instead - Yahoo Finance
CONMED (NYSE:CNMD) Draws Focus After Strong Results - Kalkine Media
CONMED (CNMD): Finishes 1.34% Lower at $50.63 in the Current Update; Key Range: the Price Remains Bounded by the Supplied Support and Resistance at the CloseBollinger Squeeze - vinanet.vn
CONMED Corporation (NYSE:CNMD) Given Average Rating of "Reduce" by Brokerages - MarketBeat
CONMED Corporation: Organic Growth Is Masked By Divestitures (NYSE:CNMD) - Seeking Alpha
The Bull Case For CONMED (CNMD) Could Change Following Shift In Regulatory Tailwinds Across Its Surgical Portfolio - Yahoo Finance
CONMED (CNMD) Shares Moved, What Is Behind The Fresh Attention? - finance.yahoo.com
Is CNMD a Buy Now as Low Valuation Meets Persistent Execution Risk? - sharewise.com
Conmed Corp Stock (CNMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
Conmed Corp Stock (CNMD) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Bronson David M. | Director |
Jun 02 '26 |
Option Exercise |
0.00 |
668 |
0 |
17,909 |
| Council LaVerne H | Director |
Jun 02 '26 |
Option Exercise |
0.00 |
668 |
0 |
4,716 |
| Farkas Charles | Director |
Jun 02 '26 |
Option Exercise |
0.00 |
668 |
0 |
15,527 |
| Kaye Mark | Director |
Jun 02 '26 |
Option Exercise |
0.00 |
668 |
0 |
820 |
| Schwarzentraub Barbara J | Director |
Jun 02 '26 |
Option Exercise |
0.00 |
668 |
0 |
5,012 |
| Lalomia Brent | Executive VP RA, QA |
Mar 06 '26 |
Option Exercise |
0.00 |
75 |
0 |
941 |
| Kaye Mark | Director |
Feb 24 '26 |
Option Exercise |
0.00 |
152 |
0 |
152 |
| Glaze Richard | Chief Information Officer |
Nov 21 '25 |
Sale |
41.21 |
257 |
10,591 |
0 |
| Glaze Richard | Officer |
Nov 21 '25 |
Proposed Sale |
41.21 |
257 |
10,591 |
0 |
| Glaze Richard | Chief Information Officer |
Nov 20 '25 |
Option Exercise |
0.00 |
375 |
0 |
375 |
1.95%
0.56%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):